European Urology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Antimicrobial prophylaxis in robot assisted laparoscopic radical prostatectomy: A systematic review
2024
-
Assessing the long-term efficacy and safety of MV140 sublingual bacterial vaccine in the initial cohort: A 9-year study in the UK for treating recurrent urinary tract infections in men and women
2024
-
Mirabegron versus placebo and other therapeutic modalities in the treatment of patients with overactive bladder syndrome - a systematic review
2024
-
Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with haematuria
2024
-
The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office
2024
-
Understanding variation in treatment intensification for de novo metastatic Castration Sensitive Prostate Cancer (mCSPC): A population-based cohort study
2024
-
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
2024
-
12-month outcomes from the first north american study of the zenflow spring system for the treatment of benign prostatic hyperplasia (BPH)
2023
-
Timing of symptomatic venous thromboembolism after surgery: A systematic review and meta-analysis
2023
-
Clinical significance of alpha 2,3-sialylated prostate-specific antigen density and MRI for high-grade prostate cancer in biopsy-naive men with elevated PSA level.
2022
-
Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial
2022
-
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study
2021
-
A systematic review of patients' values, preferences and expectations for the diagnosis and treatment of male Lower Urinary Tract Symptoms (LUTS)
2021
-
Antibiotic prophylaxis for prevention of infectious complications after shockwave lithotripsy: A systematic review and meta-analysis
2021
-
Benefits and harms of Botulinum Toxin-A in the treatment of chronic pelvic pain syndromes: Systematic review by the EAU Chronic Pelvic Pain Panel
2021
-
Effectiveness of interventions in patients who develop graft nephrolithiasis after kidney transplantation: A systematic review
2021
-
Efficacy and safety of the sublingual bacterial vaccine MV140 in women with recurrent urinary tract infections: An European phase III, multicentre, randomized, double-blind, placebo-controlled trial
2021
-
Lessons learned with remote research among older adults during COVID-19, a qualitative reflection
2021
-
Practice variation in the management of adult hydroceles: A multinational survey
2021
-
Surgical treatment in ischaemic and non-ischaemic priapism: A systematic review
2021
-
VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer..
87:512-523.
2025
-
European Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II..
S0302-2838(25)00144-7.
2025
-
Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review..
86:315-326.
2024
-
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study.
86:4-9.
2024
-
Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children.
85:433-442.
2024
-
A0638 Understanding variation in treatment intensification for de novo metastatic Castration Sensitive Prostate Cancer (mCSPC): A population-based cohort study.
85:s1571.
2024
-
A0846 Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with haematuria.
85:s1872-s1873.
2024
-
A0848 Mirabegron versus placebo and other therapeutic modalities in the treatment of patients with overactive bladder syndrome – a systematic review.
85:s1876-s1877.
2024
-
A0858 The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office.
85:s1892.
2024
-
Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS): An international, multicentre, randomised pragmatic trial.
85:S409-S410.
2024
-
Bladder cancer patient-derived organoids: A new frontier for personalized therapy.
85:S1909-S1910.
2024
-
Patient-derived organoids: 3D miniature models of bladder cancer.
85:S1907-S1908.
2024
-
Reply to Badar M. Mian. Prostate Biopsy: Hyperbole and Misrepresentation Versus Scientific Evidence and Equipoise. Eur Urol. 2024;85:99–100.
85:313-314.
2024
-
The role of artificial intelligence in urological cancers: An overview of systematic reviews.
85:S1880-S1880.
2024
-
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
84:361-370.
2023
-
Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification.
84:379-380.
2023
-
Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms..
84:207-222.
2023
-
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma.
84:109-116.
2023
-
Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023].
83:e166-e167.
2023
-
A1009 Timing of symptomatic venous thromboembolism after surgery: A systematic review and meta-analysis.
83:s1453-s1454.
2023
-
A1297 Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment weighted analysis.
83:s1888-s1889.
2023
-
Comparing treatment outcomes for fluoroscopic and fluoroscopy-free endourological procedures: A systematic review on behalf of the EAU urolithiasis guidelines panel.
83:S1436-S1437.
2023
-
Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma?.
83:1-2.
2023
-
European Association of Urology Guidelines on Male Urinary Incontinence.
82:387-398.
2022
-
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.
82:182-192.
2022
-
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
81:337-346.
2022
-
Clinical significance of α2,3-sialylated prostate-specific antigen density and MRI for high-grade prostate cancer in biopsy-naïve men with elevated PSA level..
81:S729-S731.
2022
-
Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial.
81:S299-S299.
2022
-
Adjuvant Immune Checkpoint Inhibition in Muscle-invasive Bladder Cancer: Is It Ready for Prime Time?.
80:679-681.
2021
-
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
80:531-545.
2021
-
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
80:374-382.
2021
-
Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374–82.
80:e77-e78.
2021
-
Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review.
80:57-68.
2021
-
A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms.
79:796-809.
2021
-
Benefits and harms of conservative, pharmacological, and surgical management options for women with bladder outlet obstruction: A systematic review from the European Association of Urology non-neurogenic female LUTS guidelines panel.
79:S437-S438.
2021
-
Management of women with overactive bladder syndrome: A systematic review with meta-analysis of benefits and potential harms of surgical and non-surgical treatment options by the EAU non-neurogenic female LUTS Guidelines panel.
79:S439-S440.
2021
-
P0169 Antibiotic prophylaxis for prevention of infectious complications after shockwave lithotripsy: A systematic review and meta-analysis.
79:s242-s243.
2021
-
P0182 Lessons learned with remote research among older adults during COVID-19, a qualitative reflection.
79:s260-s261.
2021
-
P0306 A systematic review of patients’ values, preferences and expectations for the diagnosis and treatment of male Lower Urinary Tract Symptoms (LUTS).
79:s441.
2021
-
P1141 Practice variation in the management of adult hydroceles: A multinational survey.
79:s1609-s1610.
2021
-
What are the different diagnostic tests for female Bladder Outlet Obstruction (fBOO)? A systematic review from the European Association of Urology non-neurogenic female LUTS Guidelines Panel.
79:S435-S436.
2021
-
European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate Biopsy.
79:11-15.
2021
-
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.
78:834-844.
2020
-
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.
78:546-569.
2020
-
Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis.
78:369-370.
2020
-
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
77:614-627.
2020
-
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.
77:311-317.
2020
-
Response of Primary Renal Cell Carcinoma to Systemic Therapy.
76:852-860.
2019
-
Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithiasis Guideline Panel.
76:352-367.
2019
-
Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.
76:18-23.
2019
-
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
75:967-987.
2019
-
Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis.
75:788-798.
2019
-
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
75:853-860.
2019
-
Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility: A Systematic Review and Meta-analysis.
75:615-625.
2019
-
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.
75:100-110.
2019
-
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.
75:300-309.
2019
-
Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.
74:76-83.
2018
-
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel.
73:394-405.
2018
-
Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of Urology.
73:290-300.
2018
-
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis.
73:242-251.
2018
-
Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis.
73:236-241.
2018
-
The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
73:94-108.
2018
-
Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel.
72:865-868.
2017
-
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
72:869-885.
2017
-
Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms..
72:757-769.
2017
-
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
72:801-813.
2017
-
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study.
72:821-827.
2017
-
What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review.
72:772-786.
2017
-
Reply to Philipp Dahm, Vikram Narayan, and Jae Hung Jung's Letter to the Editor re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811–9.
72:e93-e94.
2017
-
Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606–17.
72:e59-e60.
2017
-
Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel.
72:220-235.
2017
-
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
72:250-266.
2017
-
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
72:84-109.
2017
-
Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree.
71:811-819.
2017
-
Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy.
71:596-605.
2017
-
Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms..
71:391-402.
2017
-
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
70:1052-1068.
2016
-
Incidence and Remission of Nocturia: A Systematic Review and Meta-analysis.
70:372-381.
2016
-
Long-term Impact of Mode of Delivery on Stress Urinary Incontinence and Urgency Urinary Incontinence: A Systematic Review and Meta-analysis.
70:148-158.
2016
-
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel.
69:980-983.
2016
-
Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer — At What Cost? Eur Urol 2016;69:642–44.
69:644-645.
2016
-
Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
69:634-641.
2016
-
Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma..
69:634-641.
2016
-
The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.
69:624-633.
2016
-
Re: The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated with New Hormonal Agents for Castration-resistant Prostate Cancer.
69:177-178.
2016
-
Words or Wisdom: Re: The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated with New Hormonal Agents for Castration-resistant Prostate Cancer..
69:177-178.
2016
-
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction..
67:1099-1109.
2015
-
Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men.
66:752-768.
2014
-
What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women.
65:1211-1217.
2014
-
The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer.
65:3-6.
2014
-
Comorbidity Status Does Not Independently Predict Survival Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
64:518-519.
2013
-
Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review.
64:421-430.
2013
-
Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials.
63:717-723.
2013
-
Cost Effectiveness of Treatment Options for Early Prostate Cancer: Can We Put the Puzzle Pieces Together?.
63:411-412.
2013
-
Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests?.
61:746-748.
2012
-
Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer.
61:363-369.
2012
-
Reply to YiJun Shen and DingWei Ye's Letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer. Eur Urol 2012;61:363–9.
61:e4-e5.
2012
-
Non–Risk-Adapted Surveillance in Clinical Stage I Nonseminomatous Germ Cell Tumors: The Princess Margaret Hospital’s Experience.
59:556-562.
2011
-
The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study..
59:629-636.
2011
-
Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland..
57:488-496.
2010
-
Re: Gunnar Aus, Christopher Chapple, Tomas Hanûs, et al. The European Association of Urology (EAU) Guidelines Methodology: A Critical Evaluation. Eur Urol 2009;56:859–64.
56:e21-e22.
2009
-
Systematic Review and Meta-Analysis of Robotic-Assisted versus Conventional Laparoscopic Pyeloplasty for Patients with Ureteropelvic Junction Obstruction: Effect on Operative Time, Length of Hospital Stay, Postoperative Complications, and Success Rate.
56:848-858.
2009
-
Testosterone and Prostate Cancer: Revisiting Old Paradigms.
56:48-56.
2009
-
Editorial Comment on: Metastin Inhibits Migration and Invasion of Renal Cell Carcinoma with Overexpression of Metastin Receptor.
55:450-451.
2009
-
Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney.
54:866-874.
2008
-
Editorial Comment on: Photodynamic Diagnosis in Urology: State-of-the-Art.
53:1149-1150.
2008
-
12-YEAR EXPERIENCE USING THE DORMIA BASKET FOR THE EXTRACTION OF URETERIC STONES.
9:93-96.
1983
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)